These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 36238545)

  • 21. The C2 catalytic domain of adenylyl cyclase contains the second metal ion (Mn2+) binding site.
    Mitterauer T; Hohenegger M; Tang WJ; Nanoff C; Freissmuth M
    Biochemistry; 1998 Nov; 37(46):16183-91. PubMed ID: 9819210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of adenylyl and guanylyl cyclase isoforms by the antiviral drug foscarnet.
    Kudlacek O; Mitterauer T; Nanoff C; Hohenegger M; Tang WJ; Freissmuth M; Kleuss C
    J Biol Chem; 2001 Feb; 276(5):3010-6. PubMed ID: 11050094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The conserved asparagine and arginine are essential for catalysis of mammalian adenylyl cyclase.
    Yan SZ; Huang ZH; Shaw RS; Tang WJ
    J Biol Chem; 1997 May; 272(19):12342-9. PubMed ID: 9139678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Broad specificity of mammalian adenylyl cyclase for interaction with 2',3'-substituted purine- and pyrimidine nucleotide inhibitors.
    Mou TC; Gille A; Suryanarayana S; Richter M; Seifert R; Sprang SR
    Mol Pharmacol; 2006 Sep; 70(3):878-86. PubMed ID: 16766715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibitors of membranous adenylyl cyclases.
    Seifert R; Lushington GH; Mou TC; Gille A; Sprang SR
    Trends Pharmacol Sci; 2012 Feb; 33(2):64-78. PubMed ID: 22100304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mammalian Nucleotidyl Cyclases and Their Nucleotide Binding Sites.
    Dove S
    Handb Exp Pharmacol; 2017; 238():49-66. PubMed ID: 27900607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Class III nucleotide cyclases in bacteria and archaebacteria: lineage-specific expansion of adenylyl cyclases and a dearth of guanylyl cyclases.
    Shenroy AR; Visweswariah SS
    FEBS Lett; 2004 Mar; 561(1-3):11-21. PubMed ID: 15043055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Guanylyl cyclases in unicellular organisms.
    Linder JU; Schultz JE
    Mol Cell Biochem; 2002 Jan; 230(1-2):149-58. PubMed ID: 11952090
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural basis for the inhibition of mammalian membrane adenylyl cyclase by 2 '(3')-O-(N-Methylanthraniloyl)-guanosine 5 '-triphosphate.
    Mou TC; Gille A; Fancy DA; Seifert R; Sprang SR
    J Biol Chem; 2005 Feb; 280(8):7253-61. PubMed ID: 15591060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential inhibition of adenylyl cyclase isoforms and soluble guanylyl cyclase by purine and pyrimidine nucleotides.
    Gille A; Lushington GH; Mou TC; Doughty MB; Johnson RA; Seifert R
    J Biol Chem; 2004 May; 279(19):19955-69. PubMed ID: 14981084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conservation of functional domain structure in bicarbonate-regulated "soluble" adenylyl cyclases in bacteria and eukaryotes.
    Kobayashi M; Buck J; Levin LR
    Dev Genes Evol; 2004 Oct; 214(10):503-9. PubMed ID: 15322879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A GAF-domain-regulated adenylyl cyclase from Anabaena is a self-activating cAMP switch.
    Kanacher T; Schultz A; Linder JU; Schultz JE
    EMBO J; 2002 Jul; 21(14):3672-80. PubMed ID: 12110580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of HAMP domains on class IIIb adenylyl cyclases from Mycobacterium tuberculosis.
    Linder JU; Hammer A; Schultz JE
    Eur J Biochem; 2004 Jun; 271(12):2446-51. PubMed ID: 15182360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug therapy aimed at adenylyl cyclase to regulate cyclic nucleotide signaling.
    Iwatsubo K; Okumura S; Ishikawa Y
    Endocr Metab Immune Disord Drug Targets; 2006 Sep; 6(3):239-47. PubMed ID: 17017975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adenylyl cyclase 3/adenylyl cyclase-associated protein 1 (CAP1) complex mediates the anti-migratory effect of forskolin in pancreatic cancer cells.
    Quinn SN; Graves SH; Dains-McGahee C; Friedman EM; Hassan H; Witkowski P; Sabbatini ME
    Mol Carcinog; 2017 Apr; 56(4):1344-1360. PubMed ID: 27891679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Guanylyl cyclases across the tree of life.
    Schaap P
    Front Biosci; 2005 May; 10():1485-98. PubMed ID: 15769639
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The origin of photoactivated adenylyl cyclase (PAC), the Euglena blue-light receptor: phylogenetic analysis of orthologues of PAC subunits from several euglenoids and trypanosome-type adenylyl cyclases from Euglena gracilis.
    Koumura Y; Suzuki T; Yoshikawa S; Watanabe M; Iseki M
    Photochem Photobiol Sci; 2004 Jun; 3(6):580-6. PubMed ID: 15170488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conversion of forskolin-insensitive to forskolin-sensitive (mouse-type IX) adenylyl cyclase.
    Yan SZ; Huang ZH; Andrews RK; Tang WJ
    Mol Pharmacol; 1998 Feb; 53(2):182-7. PubMed ID: 9463474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural analysis of human soluble adenylyl cyclase and crystal structures of its nucleotide complexes-implications for cyclase catalysis and evolution.
    Kleinboelting S; van den Heuvel J; Steegborn C
    FEBS J; 2014 Sep; 281(18):4151-64. PubMed ID: 25040695
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protein kinase C inhibits type VI adenylyl cyclase by phosphorylating the regulatory N domain and two catalytic C1 and C2 domains.
    Lin TH; Lai HL; Kao YY; Sun CN; Hwang MJ; Chern Y
    J Biol Chem; 2002 May; 277(18):15721-8. PubMed ID: 11877398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.